Opportunity Information: Apply for HRSA 25 046
The AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF) opportunity is a discretionary grant run by the U.S. Department of Health and Human Services through the Health Resources and Services Administration (HRSA). It sits within the Ryan White HIV/AIDS Program (RWHAP) Part B framework and is administered by HRSA's HIV/AIDS Bureau (HAB), specifically the Division of State HIV/AIDS Programs (DSHAP). The core purpose of the program is to provide time-sensitive, targeted funding to help states and territories maintain access to HIV medications and related treatment support when their ADAP programs face a financial shortfall or a sudden increase in demand that could otherwise disrupt services.
The central idea behind ADAP ERF is emergency stabilization. These awards are meant for states and territories that can clearly show they need additional resources because available ADAP funding has dropped or because the number of people needing services has grown beyond what current resources can support. HRSA bases funding decisions on the applicant's ability to demonstrate that need in a convincing, data-supported way. Applications are reviewed by an external Merit Review Panel (MRP), which scores the need using criteria spelled out in the Notice of Funding Opportunity (NOFO). Historically, the most urgent scenario has been an ADAP waiting list, meaning eligible clients are delayed or unable to receive medications due to insufficient funds. For that reason, the program gives priority to addressing existing waiting lists.
A key detail in this NOFO is that, at the time it was published, there were no ADAP waiting lists nationally. Even so, HRSA is signaling that conditions can change quickly, and the ERF mechanism is meant to prevent backsliding. If a state or territory establishes a waiting list after the NOFO is published, it must notify HRSA immediately and is expected to use any awarded ERF funds to remove clients from the waiting list. This reflects the program's emphasis on continuity of HIV treatment and the public health importance of keeping people on effective antiretroviral therapy without interruption.
Compared with earlier years, HRSA has also broadened the practical framing of why ERF may be needed. When the initiative first launched in August 2010, many jurisdictions were experiencing waiting lists. Previously, eligibility was more closely tied to states and territories with a history of imposing waiting lists. Under this NOFO, HRSA continues to anticipate new financial and programmatic pressures that could drive demand upward or shrink available revenue. Examples mentioned include reductions in program income or manufacturer rebates, loss of health coverage among people with HIV, and increased case finding (more people diagnosed and linked to care). ERF funds can also support jurisdictions dealing with current or projected increases in treatment needs that align with national goals like Ending the HIV Epidemic in the U.S., as well as increases in enrollment driven by new diagnoses, re-engagement in care, loss of income, or loss of insurance coverage.
Eligibility is limited and specific. Only states and territories that receive RWHAP Part B funding can apply, and they must currently meet at least one of the need-based conditions described in the NOFO. Those conditions include needing funds to reduce or eliminate an existing ADAP waiting list, actively prevent a waiting list from being implemented, address a reduction in available resources to fund ADAP, respond to a current or projected increase in treatment needs tied to Ending the HIV Epidemic efforts, or manage other increases in ADAP clients due to factors like new diagnosis, re-engagement, or coverage loss. Individuals cannot apply, and states or territories that do not meet one or more of the eligibility conditions are not allowed to submit an application.
From the funding listing details, the opportunity is titled "AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF)" with Funding Opportunity Number HRSA-25-046. It uses the grant funding instrument and falls under the health activity category, with CFDA number 93.917. The eligible applicant type is state governments (and territories operating as Part B recipients). The agency expects to make around 25 awards. The notice was created on 2024-09-03, and the original application closing date is 2024-11-04. The award ceiling is listed as 0, which typically indicates the maximum award amount is not pre-set in the public listing and will be determined based on need, available funds, and HRSA's award decisions rather than a fixed cap.
Overall, this grant opportunity is best understood as a backstop for ADAP stability: it is designed to prevent interruptions in access to HIV medications by helping Part B jurisdictions quickly address sudden financial gaps or demand spikes, with particular urgency given to preventing or eliminating waiting lists and supporting broader efforts to reduce HIV transmission and improve health outcomes through sustained treatment access.Apply for HRSA 25 046
- The Health Resources and Services Administration in the health sector is offering a public funding opportunity titled "AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.917.
- This funding opportunity was created on 2024-09-03.
- Applicants must submit their applications by 2024-11-04. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 25 candidate(s).
- Eligible applicants include: State governments, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the ADAP Emergency Relief Funds (ERF) opportunity?
The AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF) opportunity is a discretionary grant run by the U.S. Department of Health and Human Services (HHS) through the Health Resources and Services Administration (HRSA). It operates within the Ryan White HIV/AIDS Program (RWHAP) Part B framework and is administered by HRSA's HIV/AIDS Bureau (HAB), specifically the Division of State HIV/AIDS Programs (DSHAP).
What is the purpose of ADAP ERF funding?
The purpose of ADAP ERF is emergency stabilization: providing time-sensitive, targeted funding to help states and territories maintain access to HIV medications and related treatment support when an ADAP program faces a financial shortfall or a sudden increase in demand that could disrupt services.
Who administers and oversees this funding opportunity?
The program is administered by HRSA (within HHS), through HRSA's HIV/AIDS Bureau (HAB). The specific administering division noted is the Division of State HIV/AIDS Programs (DSHAP).
What is the funding opportunity number (FON) for this grant?
The Funding Opportunity Number is HRSA-25-046.
What is the official title of this funding opportunity?
The official title is "AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF)."
What type of funding instrument is used?
The opportunity uses a grant funding instrument.
What is the CFDA number associated with this opportunity?
The CFDA number is 93.917.
What activity category does this opportunity fall under?
The activity category listed for this opportunity is health.
Who is eligible to apply?
Eligibility is limited to states and territories that receive RWHAP Part B funding (that is, jurisdictions operating as Part B recipients). In addition, applicants must currently meet at least one of the need-based conditions described in the Notice of Funding Opportunity (NOFO).
Can individuals apply for ADAP ERF funding?
No. Individuals cannot apply for this opportunity.
Can a state or territory apply if it does not meet the need-based conditions?
No. States or territories that do not meet one or more of the eligibility conditions described in the NOFO are not allowed to submit an application.
What kinds of "need" make a state or territory eligible under this NOFO?
Based on the information provided, eligibility depends on meeting at least one of these need-based conditions:
- Needing funds to reduce or eliminate an existing ADAP waiting list
- Needing funds to actively prevent an ADAP waiting list from being implemented
- Needing funds to address a reduction in available resources to fund ADAP
- Needing funds to respond to a current or projected increase in treatment needs tied to Ending the HIV Epidemic efforts
- Needing funds to manage other increases in ADAP clients due to factors such as new diagnosis, re-engagement in care, loss of income, or loss of insurance/coverage loss
What does HRSA prioritize when deciding which applications to fund?
HRSA emphasizes continuity of HIV treatment and gives particular priority to addressing existing ADAP waiting lists, because waiting lists are historically among the most urgent scenarios (eligible clients are delayed or unable to receive medications due to insufficient funds).
How are applications reviewed and scored?
Applications are reviewed by an external Merit Review Panel (MRP). The panel scores the applicant's demonstrated need using criteria specified in the NOFO. HRSA bases funding decisions on whether the applicant can show a convincing, data-supported need.
What is an ADAP waiting list in the context of this program?
An ADAP waiting list refers to a situation where eligible clients are delayed or unable to receive HIV medications due to insufficient program funds. The ERF program is designed to prevent or eliminate such disruptions.
Were there ADAP waiting lists nationally at the time this NOFO was published?
No. A key detail noted is that, at the time the NOFO was published, there were no ADAP waiting lists nationally.
If a waiting list starts after the NOFO is published, what is the expectation?
If a state or territory establishes a waiting list after the NOFO is published, it must notify HRSA immediately. It is also expected to use any awarded ERF funds to remove clients from the waiting list.
What kinds of circumstances can trigger the need for ERF support besides a waiting list?
The NOFO framing recognizes that conditions can change quickly and highlights several examples of pressures that can increase need, including reductions in program income or manufacturer rebates, loss of health coverage among people with HIV, and increased case finding (more people diagnosed and linked to care). It also includes current or projected increases in treatment needs aligned with national goals such as Ending the HIV Epidemic in the U.S.
How does this opportunity relate to Ending the HIV Epidemic in the U.S.?
ERF funds may support jurisdictions experiencing current or projected increases in treatment needs that align with Ending the HIV Epidemic efforts, including increased enrollment driven by new diagnoses, re-engagement in care, or coverage loss.
How many awards does HRSA expect to make?
The agency expects to make around 25 awards.
What are the key dates listed for this opportunity?
The notice was created on 2024-09-03, and the original application closing date is 2024-11-04.
Is there a maximum (ceiling) award amount?
The award ceiling is listed as 0. This typically indicates that the maximum award amount is not pre-set in the public listing and will instead be determined based on demonstrated need, available funds, and HRSA's award decisions (rather than a fixed cap).
What is the overall role of ADAP ERF within the Ryan White Part B system?
ADAP ERF functions as a backstop for ADAP stability within RWHAP Part B. It is intended to help Part B jurisdictions quickly address sudden financial gaps or demand spikes so that access to HIV medications and related treatment support is not interrupted.
Browse more opportunities from the same category: Health
Next opportunity: Coordinating Center to Support Consortium for Neuroscience Alzheimers Disease (AD) and AD-Related Dementias (ADRD) Research in Low- and Middle-Income Countries (LMICs) (U24 Clinical Trial Not Allowed)
Previous opportunity: Grants to Support New Investigators in Conducting Research Related to Preventing Interpersonal Violence Impacting Children and Youth
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for HRSA 25 046
Applicants also applied for:
Applicants who have applied for this opportunity (HRSA 25 046) also looked into and applied for these:
| Funding Opportunity |
|---|
| Ending the HIV Epidemic in the U.S. – Ryan White HIV/AIDS Program Parts A and B Apply for HRSA 25 063 Funding Number: HRSA 25 063 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Ending the HIV Epidemic in the U.S. – Systems Coordination Provider Apply for HRSA 25 065 Funding Number: HRSA 25 065 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Ending the HIV Epidemic in the U.S. – Technical Assistance Provider Apply for HRSA 25 064 Funding Number: HRSA 25 064 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competition Apply for HRSA 25 017 Funding Number: HRSA 25 017 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competition Apply for HRSA 25 016 Funding Number: HRSA 25 016 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Cell and Gene Therapy (CGT) Access Model Apply for CMS 2P2 25 001 Funding Number: CMS 2P2 25 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $9,550,000 |
| USAID/Ethiopia Health Financing Activity Apply for 72066324RFA00012 Funding Number: 72066324RFA00012 Agency: Ethiopia USAID-Addis Ababa Category: Health Funding Amount: $40,000,000 |
| Tribal Institutional Review Board Establishment and Enhancement (TIRBEE) (R24 - Clinical Trial Not Allowed) Apply for PAR 24 260 Funding Number: PAR 24 260 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Investigating Mitochondrial-Nuclear Communication in AD/ADRD (R01 Clinical Trial Not Allowed) Apply for RFA AG 25 026 Funding Number: RFA AG 25 026 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| DFC Support Program – National Community Anti-Drug Coalition Institute (NCI) Apply for NCI NCI 24 001 Funding Number: NCI NCI 24 001 Agency: Office of National Drug Control Policy Category: Health Funding Amount: $2,500,000 |
| PMI Case Management and Social Behavior Change Project Apply for 72061224RFA00003 Funding Number: 72061224RFA00003 Agency: Malawi USAID-Lilongwe Category: Health Funding Amount: $8,000,000 |
| Optimization of Genome Editing Therapeutics for Alzheimer's Disease-Related Dementias (ADRD) (U01 - Clinical Trials Not Allowed) Apply for RFA NS 24 037 Funding Number: RFA NS 24 037 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Collaborative Science to Achieve Disruptive Innovations in Dental, Oral and Craniofacial (DOC) Research (RM1 Clinical Trial Not Allowed) Apply for RFA DE 25 004 Funding Number: RFA DE 25 004 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Population Genomic Screening in Primary Care Coordinating Center(U01 -Clinical Trials Optional) Apply for RFA HG 24 022 Funding Number: RFA HG 24 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Population Genomic Screening in Primary Care Cooperative Agreement (U01 - Clinical Trial Required) Apply for RFA HG 24 021 Funding Number: RFA HG 24 021 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Population Genomic Screening in Primary Care Sequencing Center (U01 - Clinical Trial Optional) Apply for RFA HG 24 023 Funding Number: RFA HG 24 023 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| STTR Solutions to Enable Population Genomic Screening (R41/R42 Clinical Trial Optional) Apply for PAR 24 262 Funding Number: PAR 24 262 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Wastewater Drug Indicator Evaluation on the United States Southern Border Apply for WDE WDE 24 001 Funding Number: WDE WDE 24 001 Agency: Office of National Drug Control Policy Category: Health Funding Amount: $300,000 |
| BJA FY24 Medicaid and Corrections Training and Technical Assistance Program Apply for O BJA 2024 172230 Funding Number: O BJA 2024 172230 Agency: Bureau of Justice Assistance Category: Health Funding Amount: $1,000,000 |
| SBIR Solutions to Enable Population Genomic Screening (R43/R44 Clinical Trial Optional) Apply for PAR 24 263 Funding Number: PAR 24 263 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "HRSA 25 046", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.